1. An unusual cause of fatal rapid-onset ataxia plus syndrome
- Author
-
Monika Klimkowska, Dan Hauzenberger, Inger Nennesmo, Jan Weinberg, Farouk Hashim, Evangelia Kollia, Ivan Kmezic, and Martin Paucar
- Subjects
Pathology ,medicine.medical_specialty ,Ataxia ,Neurology ,Movement disorders ,FASCIA analysis ,medicine.medical_treatment ,viruses ,JC virus ,Case Report ,medicine.disease_cause ,lcsh:RC346-429 ,Polycythemia vera ,medicine ,Hydroxyurea ,Demyelinating Disorder ,lcsh:Neurology. Diseases of the nervous system ,PML ,business.industry ,Progressive multifocal leukoencephalopathy ,virus diseases ,Immunosuppression ,medicine.disease ,JC-virus ,Neurology (clinical) ,medicine.symptom ,business - Abstract
Background Progressive multifocal leukoencephalopathy (PML) is a demyelinating disorder of the central nervous system caused by reactivation of the JC-virus and is in most cases associated with underlying immunosuppression. Acquired immune deficiency syndrome (AIDS) and hematological malignancies are well-known predisposing factors for PML. However, in the past ten years, various pharmacological agents have been associated with increased risk of PML. Based on the phenomenology PML can be divided into the cerebral form and the rare cerebellar form. Case presentation Here we describe a man affected by polycythemia vera (PCV) that was treated with hydroxyurea (HU) and developed PML. The initially PML presentation included ataxia as one of the main features. Brain MRI displayed widespread supratentorial and infratentorial lesions. Immunological analysis revealed absence of reactivity to a wide range of antigens. The course of disease was rapidly progressive with fatal outcome - autopsy ruled out leukemic transformation. Conclusion The occurrence of PML in PCV patients is very rare and has been reported only once. Movement disorders, such as ataxia, are also less frequent. In the present case the PML was likely multifactorial.
- Published
- 2017